Augmented MRI.
Improved Care.
Mission
Pixyl.Neuro
Pixyl.Neuro is a cutting-edge medical technology that harnesses the power of advanced artificial intelligence to detect anomalies and changes in brain MR images for neuroinflammatory and neurodegenerative disorders.
It has been rigorously tested, FDA cleared and certified as a CE-marked class IIa medical device by our notifying body TUV-Rheinland, ensuring unparalleled safety and efficacy for our users.
Our proprietary AI algorithms, combined with our lightning-fast computing infrastructure, enable analysis to be completed in less than five minutes, and with minimal MR protocols.
This provides doctors with rapid diagnostic support, allowing for more efficient and effective treatment plans.
We are proud to be laureate of the French Society for Radiology Data Challenge, attesting to the quality and efficacy of our technology.


Partners
At Pixyl, we are driven by a passion to transform healthcare and improve patient outcomes through innovation and collaboration. We believe that to achieve our vision, we must work closely with experts from a diverse range of fields, including medical professionals, researchers, and technologists.
By collaborating with our partners, we are able to harness a broad range of expertise and insights to push the boundaries of what’s possible in medical technology. We are dedicated to fostering a culture of collaboration and a shared commitment to our vision of transforming healthcare.
It is an honor for us to work alongside experts who share our values and dedication to improving the lives of patients and their families. Together, we will continue to deliver innovative solutions and drive progress and innovation in healthcare delivery.





Recent News

ECR 2025 heralds the expanding role of AI
VIENNA, AUSTRIA (Feb 26, 2025) – Showcasing the expanding role of AI in supporting MRI radiology reading, we are proud to present our work on

ESNR 2024 the venue for the Pixyl International User Club!
PARIS, FRANCE (Sept 25, 2024) – We had a great opportunity at #ESNR2024 to host our first International PIXYL User Club, bringing together neuroradiologists from

Pixyl receives FDA clearance for AI-powered brain MRI software Pixyl.Neuro™
GRENOBLE, FRANCE (Nov 20, 2023) – Pixyl has announced FDA 510(k) clearance for Pixyl.Neuro™, the next-generation AI software for brain MRI analysis that recently demonstrated